Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

So Murai

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Pathology, Research and Practice|July 4, 2024
Clinicopathological differences in MYC and BCL2 protein expression between primary extranodal and nodal diffuse large B-cell lymphomaYohei Sasaki, So Murai, Hidenori Hayashi, et al.
Leukemia Research|February 13, 2018
Association of red cell distribution width with clinical outcomes in myelodysplastic syndromeYuta Baba, Bungo Saito, Shotaro Shimada, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2019
Monitoring TIGIT/DNAM-1 and PVR/PVRL2 Immune Checkpoint Expression Levels in Allogeneic Stem Cell Transplantation for Acute Myeloid LeukemiaNorimichi Hattori, Yukiko Kawaguchi, Yohei Sasaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 12, 2018
[Syndrome of inappropriate secretion of antidiuretic hormone in multiple myeloma patients treated with bortezomib, lenalidomide, and dexamethasone combination therapy]Yuta Baba, Hiroshi Harada, Shotaro Shimada, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2018
Status of Natural Killer Cell Recovery in Day 21 Bone Marrow after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical OutcomeNorimichi Hattori, Bungo Saito, Yohei Sasaki, et al.
Transplantation Proceedings|November 18, 2019
Refined Disease Risk Index for Hematological Malignancies, Including Rare Disorders, After Allogeneic Stem Cell TransplantationShun Fujiwara, Norimichi Hattori, Tomoharu Matsui, et al.
International Journal of Molecular Sciences|October 26, 2024
High Ki-67 Expression Predicting a Risk Factor for the Progression of Disease within 24 Months and Microenvironment in Follicular LymphomaHinako Narita, Kai Kuroiwa, Yukiko Kawaguchi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2019
Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in AdultsNorimichi Hattori, Bungo Saito, Tomoharu Matsui, et al.
International Journal of Hematology|June 12, 2020
Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab-containing chemotherapyYukiko Kawaguchi, Bungo Saito, Ayaka Nakata, et al.
International Journal of Hematology|March 9, 2019
Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemiaNana Arai, Mayumi Homma, Maasa Abe, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Pathology, Research and Practice|July 4, 2024
Clinicopathological differences in MYC and BCL2 protein expression between primary extranodal and nodal diffuse large B-cell lymphomaYohei Sasaki, So Murai, Hidenori Hayashi, et al.
Leukemia Research|February 13, 2018
Association of red cell distribution width with clinical outcomes in myelodysplastic syndromeYuta Baba, Bungo Saito, Shotaro Shimada, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2019
Monitoring TIGIT/DNAM-1 and PVR/PVRL2 Immune Checkpoint Expression Levels in Allogeneic Stem Cell Transplantation for Acute Myeloid LeukemiaNorimichi Hattori, Yukiko Kawaguchi, Yohei Sasaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 12, 2018
[Syndrome of inappropriate secretion of antidiuretic hormone in multiple myeloma patients treated with bortezomib, lenalidomide, and dexamethasone combination therapy]Yuta Baba, Hiroshi Harada, Shotaro Shimada, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2018
Status of Natural Killer Cell Recovery in Day 21 Bone Marrow after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical OutcomeNorimichi Hattori, Bungo Saito, Yohei Sasaki, et al.
Transplantation Proceedings|November 18, 2019
Refined Disease Risk Index for Hematological Malignancies, Including Rare Disorders, After Allogeneic Stem Cell TransplantationShun Fujiwara, Norimichi Hattori, Tomoharu Matsui, et al.
International Journal of Molecular Sciences|October 26, 2024
High Ki-67 Expression Predicting a Risk Factor for the Progression of Disease within 24 Months and Microenvironment in Follicular LymphomaHinako Narita, Kai Kuroiwa, Yukiko Kawaguchi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2019
Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in AdultsNorimichi Hattori, Bungo Saito, Tomoharu Matsui, et al.
International Journal of Hematology|June 12, 2020
Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab-containing chemotherapyYukiko Kawaguchi, Bungo Saito, Ayaka Nakata, et al.
International Journal of Hematology|March 9, 2019
Impact of CD123 expression, analyzed by immunohistochemistry, on clinical outcomes in patients with acute myeloid leukemiaNana Arai, Mayumi Homma, Maasa Abe, et al.
Pageof 3